Core Scientific annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Core Scientific Capital Expenditures (CapEx) Growth & History (CORZ)
Core Scientific's capital expenditures (capex) was $729.0M for fiscal 2025.
View full Core Scientific company overviewCore Scientific annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $729.0M | $634.0M | +667.68% |
| 2024 | 2024-12-31 | $95.0M | $78.8M | +487.59% |
| 2023 | 2023-12-31 | $16.2M | −$367.8M | −95.79% |
| 2022 | 2022-12-31 | $384.0M | $384.0M | — |
| 2021 | 2021-12-31 | $0 | $0 | — |
| 2020 | 2020-12-31 | $0 | — | — |
Core Scientific quarterly capital expenditures (capex)
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Capital expenditures (CapEx) | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $565.0M | $443.7M | +365.88% |
| Q1 2026 | 2026-03-31 | $389.2M | $305.2M | +363.47% |
| Q4 2025 | 2025-12-31 | $279.2M | $250.5M | +871.03% |
| Q3 2025 | 2025-09-30 | $244.5M | $213.3M | +684.28% |
| Q2 2025 | 2025-06-30 | $121.3M | $118.1M | +3768.55% |
| Q1 2025 | 2025-03-31 | $84.0M | $52.1M | +163.31% |
| Q4 2024 | 2024-12-31 | $28.8M | $17.1M | +146.96% |
| Q3 2024 | 2024-09-30 | $31.2M | $28.4M | +1036.91% |
| Q2 2024 | 2024-06-30 | $3.1M | $2.9M | +1234.04% |
| Q1 2024 | 2024-03-31 | $31.9M | $30.4M | +1972.38% |
| Q4 2023 | 2023-12-31 | $11.6M | −$128.6M | −91.70% |
| Q3 2023 | 2023-09-30 | $2.7M | −$2.5M | −47.27% |
| Q2 2023 | 2023-06-30 | $235,000 | −$105.1M | −99.78% |
| Q1 2023 | 2023-03-31 | $1.5M | −$131.7M | −98.84% |
| Q4 2022 | 2022-12-31 | $140.2M | $24.2M | +20.82% |
| Q3 2022 | 2022-09-30 | $5.2M | −$71.8M | −93.25% |
| Q2 2022 | 2022-06-30 | $105.3M | $77.0M | +271.90% |
| Q1 2022 | 2022-03-31 | $133.2M | $122.5M | +1138.48% |
| Q4 2021 | 2021-12-31 | $116.1M | — | — |
| Q3 2021 | 2021-09-30 | $77.0M | — | — |
| Q2 2021 | 2021-06-30 | $28.3M | — | — |
| Q1 2021 | 2021-03-31 | $10.8M | — | — |
Core Scientific capital expenditures (capex) trends
Over the last five fiscal years, Core Scientific's capital expenditures (capex) increased from $0 to $729.0M, a change of $729.0M. The latest reported quarter, Q2 2026, shows $565.0M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
SEC-reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Core Scientific source filings ↗